| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | GMX-1778 | CTRPv2 | pan-cancer | AAC | 0.034 | 0.3 |
| mRNA | dabrafenib | CTRPv2 | pan-cancer | AAC | -0.046 | 0.3 |
| mRNA | BRD8958 | CTRPv2 | pan-cancer | AAC | 0.037 | 0.3 |
| mRNA | 5-FU | CTRPv2 | pan-cancer | AAC | -0.032 | 0.3 |
| mRNA | ouabain | CTRPv2 | pan-cancer | AAC | 0.033 | 0.4 |
| mRNA | A-443654 | GDSC1000 | pan-cancer | AAC | 0.048 | 0.4 |
| mRNA | Erlotinib | GDSC1000 | pan-cancer | AAC | -0.044 | 0.4 |
| mRNA | Sorafenib | GDSC1000 | pan-cancer | AAC | 0.049 | 0.4 |
| mRNA | VER-155008 | CTRPv2 | pan-cancer | AAC | -0.033 | 0.4 |
| mRNA | MG-132 | CTRPv2 | pan-cancer | AAC | 0.057 | 0.4 |